
HITLAB is excited to announce the HITLAB Breakthrough Alliance (BTA), has named Bill Taranto, president of Merck Global Health Innovation Fund, Chair of the HITLAB Breakthrough Alliance through 2024. The HITLAB Breakthrough Alliance is a membership-based health consortium whose mission is to verify and diffuse digital health innovations through the generation of exclusive, evidence-based research and insights. BTA evolved from the Digital Health Breakthrough Network (DBHN), which was… Read more »